Science Explorer Back to mapMap

Most cited papers from Netherlands Comprehensive Cancer Organisation

Netherlands Comprehensive Cancer Organisation

What are the most cited papers from Netherlands Comprehensive Cancer Organisation?

The most cited paper from Netherlands Comprehensive Cancer Organisation is "Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries" (Claudia Allemani et al., 2018), with 6,323 citations. Next come "Current and future burden of breast cancer: Global statistics for 2020 and 2040" (3,413) and "Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index" (2,999).

Showing 50 of 60 papers. Every paper with more than 427 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries Claudia Allemani et al. · The Lancet Open access595 authors 31 Jan 2018 6,323
2 Current and future burden of breast cancer: Global statistics for 2020 and 2040 Melina Arnold, Eileen Morgan, Harriet Rumgay et al. · The Breast Open access 2 Sep 2022 3,413
3 Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index MAGIC et al. · Nature Genetics Open access376 authors 10 Oct 2010 2,999
4 Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018 Jacques Ferlay, Murielle Colombet, Isabelle Soerjomataram et al. · European Journal of Cancer 9 Aug 2018 2,566
5 Hundreds of variants clustered in genomic loci and biological pathways affect human height Hana Lango Allen et al. · Nature Open access293 authors 29 Sep 2010 2,063
6 Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study Roberta De Angelis, Milena Sant, Michel P. Coleman et al. · The Lancet Oncology Open access 5 Dec 2013 1,916
7 A variant associated with nicotine dependence, lung cancer and peripheral arterial disease Thorgeir Elís Thorgeirsson et al. · Nature Open access Apr 2008 1,536
8 Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity Guðmar Þorleifsson et al. · Nature Genetics Open access 14 Dec 2008 1,416
9 Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer Jolien Tol, Miriam Koopman, Annemieke Cats et al. · New England Journal of Medicine Open access 4 Feb 2009 1,358
10 Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial Eva Versteijne et al. · Journal of Clinical Oncology Open access 27 Feb 2020 1,101
11 Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study Gemma Gatta et al. · The Lancet Oncology Open access 5 Dec 2013 1,100
12 The global burden of urinary bladder cancer: an update Anke Richters, Katja K.H. Aben, Lambertus A.L.M. Kiemeney · World Journal of Urology Open access Nov 2019 1,043
13 The present and future burden of urinary bladder cancer in the world Martine Ploeg, Katja K.H. Aben, Lambertus A.L.M. Kiemeney · World Journal of Urology Open access 15 Feb 2009 928
14 Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk Ganna Chornokur et al. · PLoS ONE Open access160 authors 19 Jun 2015 906
15 Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial Harm van Tinteren, Otto S. Hoekstra, Egbert Frederik Smit et al. · The Lancet Apr 2002 865
16 Rare cancers are not so rare: The rare cancer burden in Europe Gemma Gatta, Jan Maarten van der Zwan, Paolo Giovanni Casali et al. · European Journal of Cancer Open access 26 Oct 2011 816
17 Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer Simon Stacey et al. · Nature Genetics 27 May 2007 789
18 The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study Eileen Morgan, Melina Arnold, Maria Constanza Camargo et al. · EClinicalMedicine Open access 21 Apr 2022 782
19 Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial Eva Versteijne et al. · Journal of Clinical Oncology Open access 27 Jan 2022 755
20 Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes Jūlı́us Guðmundsson et al. · Nature Genetics Jul 2007 728
21 Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands Avinash G. Dinmohamed, Otto J. Visser, Rob H.A. Verhoeven et al. · The Lancet Oncology Open access 30 Apr 2020 726
22 Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study Harriet Rumgay, Kevin David Shield, Hadrien Charvat et al. · The Lancet Oncology Open access 30 Jul 2021 704
23 Sequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behavior Thorgeir Elís Thorgeirsson et al. · Nature Genetics Open access 25 Apr 2010 697
24 Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage study Jeanet W. Blom, Jan Vanderschoot, M.J. Oostindiër et al. · Journal of Thrombosis and Haemostasis Open access 6 Feb 2006 696
25 Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture Sonja I. Berndt et al. · Nature Genetics Open access322 authors 7 Apr 2013 688
26 Rare and low-frequency coding variants alter human adult height Eirini Marouli et al. · Nature Open access373 authors 31 Jan 2017 665
27 Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial Stephanie M. de Boer et al. · The Lancet Oncology Open access 12 Feb 2018 640
28 Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma Michael Schaapveld et al. · New England Journal of Medicine Open access 23 Dec 2015 637
29 Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial Miriam Koopman, Ninja F. Antonini, Joep Douma et al. · The Lancet Jul 2007 633
30 Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies Bart G. Pijls, Shahab Jolani, Anique Atherley et al. · BMJ Open ReviewOpen access 2021 626
31 Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD) Thijs de Rooij et al. · Annals of Surgery Open access 3 Aug 2018 625
32 Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs Laurien M. Buffart et al. · Cancer Treatment Reviews ReviewOpen access 5 Dec 2016 618
33 Sequence variants at the TERT-CLPTM1L locus associate with many cancer types Þórunn Rafnar et al. · Nature Genetics Open access 18 Jan 2009 616
34 Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial Jony van Hilst et al. · ˜The œLancet. Gastroenterology & hepatology Open access115 authors 27 Jan 2019 611
35 Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial Ben J. Slotman, Harm van Tinteren, John O. Praag et al. · The Lancet Open access 15 Sep 2014 607
36 Global, regional and national burden of primary liver cancer by subtype Harriet Rumgay, Jacques Ferlay, Catherine de Martel et al. · European Journal of Cancer Open access 20 Dec 2021 603
37 Risk of endometrial cancer after tamoxifen treatment of breast cancer Flora E. van Leeuwen, Alexandra W. van den Belt‐Dusebout, F.E. Van Leeuwen et al. · The Lancet Open access Feb 1994 571
38 Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer Catherine M. Phelan et al. · Nature Genetics Open access420 authors 27 Mar 2017 566
39 Risk and prognosis of endometrial cancer after tamoxifen for breast cancer Liesbeth Bergman, Maureen LR Beelen, M.P.W. Gallee et al. · The Lancet Sep 2000 552
40 Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer Australian Cancer Study et al. · Nature Genetics Open access443 authors 27 Mar 2013 544
41 Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases Philip Haycock et al. · JAMA Oncology Open access198 authors 27 Feb 2017 538
42 Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases Lydia G. van der Geest, Jorine’t Lam-Boer, Miriam Koopman et al. · Clinical & Experimental Metastasis Open access 21 Apr 2015 533
43 Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group Lieke H. J. Simkens et al. · The Lancet Open access 10 Apr 2015 529
44 Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study Gemma Gatta et al. · The Lancet Oncology Open access135 authors 4 Jul 2017 519
45 Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial Jan Baptist Vermorken, A.M.E. Claessen, Harm van Tinteren et al. · The Lancet Open access 1999 507
46 Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study Rafael Cardoso et al. · The Lancet Oncology Open access 25 May 2021 496
47 Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma Mark H.H Kramer, Jos H. Hermans, E.R. Wijburg et al. · Blood Nov 1998 491
48 A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci Nathaniel Rothman et al. · Nature Genetics Open access110 authors 24 Oct 2010 491
49 Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy Lieke Hol, Monique Esther van Leerdam, Marjolein van Ballegooijen et al. · Gut 10 Aug 2009 487
50 Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend Analysis David A. Palma, Otto J. Visser, Frank J. Lagerwaard et al. · Journal of Clinical Oncology 2 Nov 2010 480

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.